Riccardo Soffietti
#158,321
Most Influential Person Now
Researcher
Riccardo Soffietti's AcademicInfluence.com Rankings
Download Badge
Physics
Riccardo Soffietti's Degrees
- PhD Physics University of Milan
- Masters Physics University of Milan
- Bachelors Physics University of Milan
Why Is Riccardo Soffietti Influential?
(Suggest an Edit or Addition)Riccardo Soffietti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. (2021) (2388)
- Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. (2011) (1001)
- European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. (2017) (736)
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. (2014) (601)
- A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. (2013) (558)
- Response assessment criteria for brain metastases: proposal from the RANO group. (2015) (553)
- Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. (2016) (550)
- High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial (2009) (547)
- EANO guidelines for the diagnosis and treatment of meningiomas. (2016) (524)
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood (2020) (486)
- Guidelines on management of low‐grade gliomas: report of an EFNS–EANO * Task Force (2010) (453)
- Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force (2011) (437)
- Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) (2017) (312)
- Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. (2015) (303)
- Epidemiology of glial and non-glial brain tumours in Europe. (2012) (264)
- Prognostic factors in well-differentiated cerebral astrocytomas in the adult. (1989) (228)
- Management of brain metastases (2002) (224)
- STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis (2018) (222)
- Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. (2012) (215)
- Epilepsy and brain tumors (2010) (210)
- EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force (2006) (206)
- Updates in the management of brain metastases. (2016) (194)
- Leptomeningeal metastases: a RANO proposal for response criteria (2014) (193)
- Brain metastases. (2019) (182)
- Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial. (2019) (166)
- PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. (1998) (158)
- The Evolving Landscape of Brain Metastasis. (2018) (146)
- Brain metastases (2019) (146)
- Brain metastases: current management and new developments (2008) (144)
- EANO guidelines for the diagnosis and treatment of ependymal tumors. (2018) (134)
- A prognostic gene expression signature in infratentorial ependymoma (2012) (133)
- Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials. (2014) (132)
- Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. (2016) (127)
- Ependymomas in Adults (2010) (125)
- The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria (2014) (120)
- Histologic prognostic factors in ependymoma (1991) (117)
- Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. (2013) (115)
- Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. (2013) (109)
- PET imaging in patients with brain metastasis-report of the RANO/PET group. (2019) (108)
- EANO guideline on the diagnosis and management of meningiomas. (2021) (101)
- Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. (2015) (98)
- Mechanisms and Therapy for Cancer Metastasis to the Brain (2018) (96)
- Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life (2011) (93)
- Ependymoma: internal correlations among pathological signs: the anaplastic variant. (1991) (88)
- The addition of rituximab to anthracycline‐based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B‐cell lymphoma (2008) (88)
- Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group. (2018) (86)
- Primitive cerebral melanoma: case report and review of the literature. (2001) (82)
- The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection (2020) (81)
- Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications (2019) (81)
- Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. (2013) (77)
- Targeted therapy in brain metastasis (2012) (74)
- Management of brain metastases according to molecular subtypes (2020) (73)
- Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology) (2013) (72)
- Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: Response, Progression, and Pseudoprogression. (2019) (71)
- Ependymomas of the adult: molecular biology and treatment (2008) (71)
- Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma (2017) (68)
- Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring (2018) (66)
- Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial (2019) (65)
- Prognostic value of histologic factors in adult cerebral astrocytoma (1988) (60)
- Natural history and management of brainstem gliomas in adults (2008) (56)
- NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target (2020) (56)
- Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of the EORTC 22952-26001 study. (2009) (53)
- Breast cancer brain metastasis: molecular mechanisms and directions for treatment. (2018) (52)
- Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas. (2016) (50)
- Histological Predictors of Outcome in Ependymoma are Dependent on Anatomic Site Within the Central Nervous System (2013) (48)
- Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. (2016) (47)
- Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group. (2021) (45)
- Prognostic Factors in Adult Medulloblastoma. A Clinico-Pathologic Study (1995) (44)
- Brain metastases from unknown primary tumour (2001) (44)
- Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors. (2006) (44)
- Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012. (2012) (43)
- Neurologic complications of chemotherapy and other newer and experimental approaches. (2014) (42)
- MGMT promoter methylation in plasma of glioma patients receiving temozolomide (2014) (42)
- Radiotherapy and chemotherapy of brain metastases (2005) (42)
- Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe (2016) (40)
- Association of Supratotal Resection with Progression-Free Survival, Malignant Transformation, and Overall Survival in Lower-Grade Gliomas. (2020) (40)
- What is New in the Management of Epilepsy in Gliomas? (2015) (38)
- Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. (2018) (37)
- Second‐line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy (2004) (36)
- Brain metastases from unknown primary tumour: a prospective study. (2001) (31)
- Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system. (2020) (29)
- Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper. (2017) (29)
- Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study. (2016) (29)
- Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001 (2017) (27)
- Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop. (2014) (27)
- Phase 0 and Window of Opportunity Clinical Trial Design in Neuro-Oncology: A RANO Review. (2020) (27)
- Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study (2017) (26)
- EAN consensus statement for management of patients with neurological diseases during the COVID‐19 pandemic (2020) (25)
- Primary Lymphomas of the Brain: A Clinico-Pathologic Review of 37 Cases (1987) (24)
- Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance (2021) (23)
- Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps (2016) (23)
- MRI diagnosis of intramedullary metastases from extra-CNS tumors (2007) (23)
- Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC). (2019) (22)
- A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme. (2015) (22)
- Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management. (2017) (22)
- What have we learned from trials on antiangiogenic agents in glioblastoma? (2014) (22)
- Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas (2016) (21)
- Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma (2015) (21)
- New developments in the treatment of malignant gliomas (2007) (20)
- Use of Antidepressants and Risk of Incident Stroke: A Systematic Review and Meta-Analysis (2019) (20)
- Caveolin 1 Expression Independently Predicts Shorter Survival in Oligodendrogliomas (2009) (19)
- 8704 Adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of 1–3 cerebral metastases results of the EORTC 22952–26001 study (2009) (18)
- Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016 (2019) (18)
- Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy (2004) (18)
- Trabectedin for recurrent WHO grade II or III meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG). (2019) (17)
- Chemotherapy of anaplastic oligodendroglial tumours (2004) (17)
- Anti-angiogenic approaches to malignant gliomas. (2012) (16)
- Phase II trial of bevacizumab with fotemustine in recurrent glioblastoma: Final results of a multicenter study of AINO (Italian Association of Neuro-oncology). (2011) (15)
- Paraneoplastic opsoclonus: a neuropathologic study of two cases. (1989) (15)
- Phase II study of bevacizumab and nitrosourea in patients with recurrent malignant glioma: A multicenter Italian study. (2009) (15)
- A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: The NeuroCOVID‐19 Task Force of the European Academy of Neurology (2021) (15)
- Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches (2021) (15)
- On the nature of the so-called monstrocellular sarcoma of the brain. (1980) (15)
- Delayed adverse effects after irradiation of gliomas: clinicopathological analysis (2005) (15)
- Association between multiple sclerosis and oligodendroglioma. Case report. (1981) (15)
- Supratotal Resection of Glioblastoma: Is Less More? (2019) (14)
- Addition of Thiotepa and Rituximab to Antimetabolites Significantly Improves Outcome in Primary CNS Lymphoma: First Randomization of the IELSG32 Trial. (2015) (14)
- Antiangiogenic therapy of brain tumors: the role of bevacizumab (2014) (14)
- Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments (2018) (14)
- Skin metastases of glioblastoma in the absence of intracranial progression are associated with a shift towards a mesenchymal immunophenotype: report of two cases (2009) (13)
- Pharmacologic Therapies for Malignant Glioma: A Guide for Clinicians (2014) (13)
- Rare glial tumors. (2016) (13)
- The Neurologic Assessment in Neuro-Oncology (NANO) Scale: A Tool to Assess Neurologic Function for Integration in the Radiologic Assessment in Neuro-Oncology (RANO) Criteria (S22.005) (2014) (13)
- Overview on current treatment standards in high-grade gliomas. (2018) (13)
- Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept (2016) (13)
- Treatment of brain metastasis: current status and future directions (2016) (12)
- Management of Brain and Leptomeningeal Metastases from Breast Cancer (2020) (12)
- Radio- and chemotherapy of malignant gliomas. Pathological changes in the normal nervous tissue (2005) (12)
- Ependymoma: internal correlations among pathological signs (1991) (12)
- European Association of Neuro-Oncology (EANO) Guidelines for Treatment of Primary Central Nervous System lymphoma (PCNSL). (2022) (12)
- The legend of cytomegalovirus and glioblastoma lives on. (2014) (11)
- Review: Peering through a keyhole: liquid biopsy in primary and metastatic central nervous system tumours (2019) (11)
- Primary prevention of COVID‐19: Advocacy for vaccination from a neurological perspective (2021) (11)
- Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersocieties (SINch/AINO/SIN) document. (2020) (11)
- Brain metastases (2021) (11)
- Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG). (2021) (11)
- Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism (2022) (11)
- Does valproic acid affect tumor growth and improve survival in glioblastomas? (2016) (11)
- Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors. (2019) (10)
- The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy. (2021) (10)
- Molecularly based management of gliomas in clinical practice (2015) (10)
- Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome (2019) (10)
- Controversies in management of low-grade gliomas in light of new data from clinical trials. (2017) (10)
- Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series (2018) (10)
- Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study (2020) (10)
- Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study. (2017) (10)
- Pathology of human malignant gliomas after radiation and chemotherapy (2005) (10)
- Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration (2018) (9)
- Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis (2008) (9)
- A call from the European Academy of Neurology on COVID-19 (2020) (9)
- Vascular response to irradiation in malignant gliomas (1990) (9)
- Proliferating Cell Nuclear Antigen (PCNA) in Low-Grade Astrocytomas: Its Prognostic Significance (1994) (9)
- Low-grade gliomas. (2012) (8)
- The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors. (2009) (8)
- Quality-of-life results of an EORTC phase III randomized trial of adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases of solid tumors. (2010) (8)
- Temozolomide in rare brain tumors of the adult: a prospective study (2005) (8)
- Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination (2010) (8)
- Imaging and clinical end points in brain metastases trials. (2017) (8)
- Prognostic Factors and Current Treatment Strategies for Renal Cell Carcinoma Metastatic to the Brain: An Overview (2021) (8)
- Author Correction: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis (2018) (7)
- Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas (2004) (7)
- Current clinical management of elderly patients with glioma (2020) (7)
- Evaluation of the 2020 European Academy of Neurology virtual congress: transition from a face‐to‐face to a virtual meeting (2020) (7)
- Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series. (2019) (7)
- Brain Metastasis from Unknown Primary Tumour: Moving from Old Retrospective Studies to Clinical Trials on Targeted Agents (2020) (7)
- Lonidamine in malignant brain tumors. (1991) (6)
- Eano-Euracan-Sno Guidelines on Circumscribed Astrocytic GLIOMAS, Glioneuronal and Neuronaltumors. (2022) (6)
- Extent of surgery in low-grade gliomas: an old question in a new context. (2018) (6)
- Successful use of bevacizumab in an adult primary diffuse leptomeningeal glioneuronal tumor. (2016) (6)
- Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors (2019) (6)
- Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016 (2019) (6)
- The position of the neurologist in neuro‐oncology 1 (2002) (6)
- Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring. (2019) (6)
- COVID‐19 vaccination hesitancy among people with chronic neurological disorders: A position paper (2022) (6)
- What Have We Learned from Recent Clinical Studies in Low-Grade Gliomas? (2018) (6)
- New chemotherapy options for the treatment of malignant gliomas (2007) (6)
- Liquid biopsy in gliomas: a RANO review and proposals for clinical applications. (2022) (6)
- Treatment of gliomatosis cerebri with temozolomide: A retrospective study of the AINO (Italian Association for Neuro- Oncology) (2007) (6)
- Basic mechanisms of epilepsy (2002) (6)
- Bevacizumab Treatment for Vestibular Schwannoma in a Patient with Neurofibromatosis Type 2: Hearing Improvement and Tumor Shrinkage (2015) (5)
- Brain Metastasis as Complication of Systemic Cancers (2018) (5)
- Neratinib and Capecitabine for the Treatment of Leptomeningeal Metastases from HER2-Positive Breast Cancer: A Series in the Setting of a Compassionate Program (2022) (5)
- IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups. (2021) (5)
- Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group. (2022) (5)
- Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand? (2022) (5)
- Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014). (2014) (5)
- Phase II trial of bevacizumab and fotemustine in recurrent grade III gliomas. (2012) (5)
- Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study (2017) (5)
- Temozolomide (TMZ) 1 week on/1 week off as initial treatment for progressive low grade oligodendroglial tumors: A phase II AINO study (2008) (5)
- A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis (2022) (5)
- NEURO/MEDICAL ONCOLOGY (2013) (4)
- Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances (2020) (4)
- Neuro-oncology: new insights and advances in treatment (2008) (4)
- Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas? (2020) (4)
- Evidence-based management of adult patients with diffuse glioma - Authors' reply. (2017) (4)
- Richter’s Syndrome of the Central Nervous System (2021) (4)
- PL3.2 Trabectedin for recurrent WHO grade II or III meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG) (2019) (4)
- Screening for Tumours in Paraneoplastic Syndromes (2011) (4)
- Pembrolizumab-Induced Isolated Cranial Neuropathy: A Rare Case Report and Review of Literature (2021) (4)
- Natural History and Spontaneous Prognostic Factors (2013) (4)
- Guidelines on the Management of Low-grade Gliomas: EANO Task Force Report (2012) (4)
- Oral Scientific SessionsComparison of Local Control of Brain Metastasis with Stereotactic Radiosurgery Versus Surgical Resection: A Secondary Analysis of EORTC 22952-26001 (2017) (4)
- Glioblastoma in the Elderly: Review of Molecular and Therapeutic Aspects (2022) (3)
- Efficacy of radiation therapy on epileptic seizures of grade 2 and 3 gliomas: A retrospective study. (2011) (3)
- A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis (2020) (3)
- Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management. (2017) (3)
- O9.09EFFICACY AND TOLERABILITY OF LACOSAMIDE IN PATIENTS WITH GLIOMA: A PROSPECTIVE STUDY. (2014) (3)
- Ependymoma: Evaluation and Management Updates (2022) (3)
- Editorial to Special Issue (2013) (3)
- A phase II study of first-line temozolomide and second-line PCV in recurrent/progressive malignant gliomas. (2004) (3)
- Neuro-oncology perspective of treatment options in metastatic breast cancer. (2018) (3)
- Phase II trial of dose-dense temozolomide as initial treatment for progressive low-grade oligodendroglial tumors: A multicentric study of the Italian Association of Neuro-Oncology (AINO). (2012) (3)
- Automatic segmentation and therapy follow-up of cerebral glioma in diffusion-tensor images (2010) (3)
- MGMT gene promoter methylation in plasma of glioma patients receiving temozolomide. (2014) (3)
- P14.42 Neratinib for treatment of leptomeningeal metastases from HER2-positive breast cancer in extended access program: preliminary results (2021) (3)
- Targeted Therapies in Rare Brain Tumours (2021) (3)
- Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology (2018) (3)
- Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response (2016) (3)
- Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib in relapsed glioblastoma (GBM) patients (PTS). (2018) (3)
- Pineal Gland Tumors (1993) (3)
- Strategies to prevent brain metastasis. (2019) (3)
- Systemic Therapy for Lung Cancer Brain Metastases (2021) (3)
- Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood (2022) (3)
- Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma: First results from the ETERNITY study (EORTC 1419). (2019) (3)
- Tissue alterations induced by radio- and chemotherapy in brain with malignant gliomas. (1981) (3)
- Histologic and clinical factors of prognostic significance in astrocytic gliomas. (1990) (3)
- Radiotherapy as salvage treatment for immunocompetent primary non-Hodgkin's CNS lymphomas: An Italian study (2000) (2)
- Ependymomas, neuronal and mixed neuronal-glial tumors, dysembroblastic neuroepithelial tumors, pleomorphic xanthoastrocytomas, and pilocytic astrocytomas. (2012) (2)
- Does Whole-Brain Radiation Therapy for Oligometastatic Brain Metastases Translate Into a Survival Benefit for Patients With a Limited Competing Risk From Extracranial Disease? A Secondary Analysis of EORTC 22952-26001 (2016) (2)
- EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology (2012) (2)
- Evaluation of changes in gliomas structural features after chemotherapy using DTI-based Functional Diffusion Maps ( fDMs ) : a preliminary study with intraoperative correlation (2010) (2)
- Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis? (2016) (2)
- Effects of radiotherapy on the astrocytomatous areas of malignant gliomas (2004) (2)
- STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis (2018) (2)
- Second-line PCV in recurrent or progressive glioblastomas: A phase II study (2006) (2)
- A Pathologic Study of Malignant Gliomas Operated after Radio- and Chemotherapy (1981) (2)
- Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study (2016) (2)
- Reply to M.C. Chamberlain and C. Gemici. (2013) (2)
- Spinal melanocytoma with leptomeningeal spread and long survival following surgery and chemotherapy. (2016) (2)
- Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. (2022) (2)
- O8.01PRE-OPERATIVE CHEMOTHERAPY AS A NEW STRATEGY IN TREATING LOW GRADE GLIOMAS IN ELOQUENT AREAS (2014) (1)
- Medical and Neuro-Oncology (2010) (1)
- Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy? (2022) (1)
- Medulloblastoma in adults: an analysis of clinico-pathological, molecular and treatment factors. (2021) (1)
- Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study. (2022) (1)
- P14.77 Efficacy and safety of Tumor-Treating Fields associated with Depatux M and metronomic temozolomide for recurrent glioblastoma: a case-report (2021) (1)
- 8719 Salvage therapy with bevacizumab and fotemustine in recurrent high grade gliomas (2009) (1)
- Recurrence of well-differentiated astrocytomas and malignant transformation (1987) (1)
- [Long-term results of the treatment of infantile medulloblastoma]. (1983) (1)
- Brain metastasis from HER2-positive breast cancer: an evolving landscape. (2022) (1)
- TEMOZOLOMIDE FOR RECURRENT INTRACRANIAL EPENDYMOMA OF THE ADULT: PATTERNS OF RESPONSE, SURVIVAL AND CORRELATIONS WITH MGMT PROMOTER METHYLATION (2014) (1)
- P21.03 Efficacy of bevacizumab in a primary diffuse leptomeningeal glioneuronal tumor of the adult (2016) (1)
- Health-related quality of life (HRQoL) evaluation in the REGOMA trial: A randomized, phase II clinical trial analyzing regorafenib activity in relapsed glioblastoma patients. (2019) (1)
- P01.116 Treatment with Dabrafenib in a patient with BRAF mutated recurrent ganglioglioma (2018) (1)
- Ependymoma: current treatment options and a look to the future. (2013) (1)
- Recurrent/progressive oligodendroglial tumors: A phase II study with temozolomide as first line chemotherapy. (2006) (1)
- A phase II trial of temozolomide (TMZ) 1 week on/1 week off as initial treatment for high risk low grade oligodendroglial tumors: An AINO (Italian Association for Neuro-Oncology) study. (2017) (1)
- Perspectives of Personalized Chemotherapy of Gliomas Based on Molecular Tumor Profiling. (2018) (1)
- ACTR-06. DOSE DENSE TEMOZOLOMIDE (TMZ) AS INITIAL TREATMENT FOR HIGH-RISK OLIGODENDROGLIAL TUMORS: LONG-TERM RESULTS OF A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY (2017) (1)
- Does an Optimal Management of Brain Metastases from Oncogenic-Driver Non-Small Cell Lung Cancer Exist? (2019) (1)
- P06.08SYSTEMIC TREATMENT OF MENINGIOMAS: IS THERE A ROLE FOR LONG-ACTING SOMATOSTATIN? (2014) (1)
- Prevention Strategies for Brain Metastasis (2019) (1)
- ACTR-20. EFFICACY OF INITIAL TEMOZOLOMIDE FOR HIGH-RISK LOW GRADE GLIOMAS IN A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY: A POST-HOC ANALYSIS WITHIN MOLECULAR SUBGROUPS OF WHO 2016 (2019) (1)
- Primary Central Nervous System Lymphomas (1997) (1)
- Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial (2015) (1)
- TMIC-01. STAT3 EXPRESSION IN BRAIN METASTASES FROM BREAST CANCER: CORRELATIONS WITH DIFFERENT MOLECULAR SUBTYPES AND CLINICAL OUTCOME (2022) (1)
- Molecular Genetic, Host-Derived and Clinical Determinants of Long-Term Survival in Glioblastoma: First Results from the Brain Tumor Funders' Collaborative Consortium (2016) (1)
- Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014). (2014) (1)
- Choosing appropriate chemotherapy for diffusely infiltrating WHO grade II gliomas in adults (2020) (1)
- Prognostic factors in anaplastic astrocytomas after surgery and conventional radiotherapy (1991) (1)
- Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery (2020) (1)
- 42. IDENTIFICATION OF BRAIN METASTASIS VULNERABILITIES USING METPLATFORM (2020) (0)
- Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma (2015) (0)
- Tumors of the Meninges (1993) (0)
- CLIN-NEURO/MEDICAL ONCOLOGY (2012) (0)
- P13.04 Practice patterns of diagnosis and management of leptomeningeal metastasis in Europe: results from a web-based survey (2016) (0)
- Long-term survival of a sacro-coccygeal myxopapillary ependymoma with extra-neural metastases: case report and review of the literature (2020) (0)
- 2900 Predictors of survival in glioblastoma patients treated with fotemustine at first relapse after Stupp regimen: Analysis of GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology) (2015) (0)
- Third Annual Congress of the Italian Association of Neuro-Oncology (1993) (0)
- Comprar Handbook Of Clinical Neurology, Vol. 105: Neuro-Oncology Part II | Wolfgang Grisold | 9780444535023 | Elsevier Internacional (2012) (0)
- Highlights from the literature (1960) (0)
- Abstract 653: Gliomas: methylation status of MGMT gene monitoring in plasma DNA of patients receiving chemotherapy with alkylating agents. (2013) (0)
- Delayed radio necrosis following concentrated split course radio therapy a case (1982) (0)
- Automatic Segmentation and Therapy Followup of Cerebral Glioma in DiffusionTensor Images (2010) (0)
- Spinal epidural metastases (2016) (0)
- SP-0572 CURRENT PRACTICE AND MOVING POINTS: PRIMARY BRAIN (2012) (0)
- P-190 A prognostic factors analysis of fractionated stereotactic radiotherapy in the treatment of patients with brain metastases from non small cell lung carcinoma (2003) (0)
- Evidence-based approaches to chemotherapy for gliomas (2021) (0)
- Editorial: Neuro-oncology is moving ahead: new perspectives and critical issues. (2020) (0)
- Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter? (2023) (0)
- ACTR-54. PATTERN OF RECURRENCE AND IMPACT ON SURVIVAL OF SALVAGE THERAPIES IN LOW-GRADE GLIOMAS FOLLOWING DOSE-DENSE TEMOZOLOMIDE (2018) (0)
- R03Prognostic factors in glioblastoma patients treated with the nitrosourea fotemustine at first relapse after the Stupp regimen: results from the GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology) (2015) (0)
- Khalida WaniTerri S. ArmstrongElizabeth Vera-BolanosAditya RaghunathanDavid Ellison • Richard GilbertsonBrian VaillantStewart GoldmanRoger J. PackerMaryam FouladiIan Pollack • Tom MikkelsenMichael PradosAntonio OmuroRiccardo SoffiettiAlicia LedouxCharmaine Wilson • Lihong LongMark R. GilbertKen Alda (2012) (0)
- Supratotal Resection of Glioblastoma : Is Less More ?-1-# 1167 (2019) (0)
- Resectable central nervous system (CNS) metastases from colorectal cancer (CRC): Patient characteristics, outcome, and molecular correlations between primary tumor and metastases. (2017) (0)
- Author Correction: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis (2018) (0)
- P12.04GLIOMATOSIS CEREBRI: IS THERE A ROLE FOR SURGERY OTHER THAN BIOPSY? (2014) (0)
- Tumors of the Central Nervous System: Therapeutic Approaches (2019) (0)
- Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression. (2013) (0)
- OS06.7A METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy (2021) (0)
- P13.19HYPOFRACTIONATED RADIOTHERAPY IN PATIENTS WITH HIGH GRADE GLIOMAS AND POOR PROGNOSTIC FACTORS: A RETROSPECTIVE STUDY (2014) (0)
- P17.58DETECTION OF HUMAN PAPILLOMA VIRUS DNA IN A SUBSET OF GLIOBLASTOMA SAMPLES (2014) (0)
- P08.58 Upfront chemotherapy in grade III gliomas: an institutional retrospective series. (2016) (0)
- Contributors List (2021) (0)
- Diffusion Tensor Imaging-based Histogram Analysis for detection and quantification of low-grade gliomas structural changes during chemotherapy (2013) (0)
- P09.41 Single agent Bevacizumab in recurrent glioblastoma after a second line chemotherapy with Fotemustine. The Italian Association of Neuro Oncology experience (2017) (0)
- P08.33 GLIOSTRY (Glioblastoma Registry) of the AINO (Italian Association of Neuro-Oncology): final analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first progression following chemoradiation. (2016) (0)
- OS3.1 IDH-wild type grade II gliomas: a retrospective series of AINO (Italian Association of Neuro-Oncology) (2018) (0)
- S100A9 mediates resistance of brain metastasis to radiation therapy. (2018) (0)
- Highlights from the literature (2014) (0)
- Biological Basis of Therapies (1993) (0)
- OS5.5 Supratotal resection in low grade gliomas (LGGs): feasibility and clinical impact. (2016) (0)
- Primary limphomas of the brain (1987) (0)
- P14.85 Brain metastasis from Hodgkin’s Lymphoma: case report and literature review (2019) (0)
- P04.09 Patterns of care and impact on survival of first salvage therapy in high-risk grade II gliomas following initial temozolomide (2019) (0)
- P05.49 Extra-neural metastases from a sacro-coccygeal myxopapillary ependymoma: a case report (2018) (0)
- [Cerebral metastatis. Diagnostic and therapeutic features]. (2000) (0)
- Central Nervous System Metastases (2020) (0)
- IDH-wild type low grade gliomas: An AINO (Italian Association of Neuro-Oncology) retrospective study. (2018) (0)
- SURG-10. The evolving role of neurosurgery for central nervous system metastases in the era of personalized medicine (2021) (0)
- OS03.7 Does improved intracranial control from whole brain radiation therapy translate to improved overall survival in patients with limited competing risk from systemic disease? A secondary analysis of EORTC 22952–26001. (2017) (0)
- Natural history and management of well differentiated astrocytomas of the cerebral hemispheres (1988) (0)
- RADI-03. A strategy to personalize the use of radiation in patients with brain metastasis based on S100A9-mediated resistance (2021) (0)
- Adverse effects of antiepileptic drugs in brain tumors: Preliminary data of a multi-institutional survey. Are new antiepileptic drugs less toxic? (2005) (0)
- P15.10COGNITIVE AND FUNCTIONAL STATUS OF PATIENTS AND QUALITY OF LIFE OF CAREGIVERS: A PROSPECTIVE STUDY IN A COHORT OF RECURRENT GLIOBLASTOMAS. (2014) (0)
- PRE-OPERATIVE CHEMOTHERAPY AS A NEW STRATEGY OF TREATMENT FOR LOW GRADE GLIOMAS IN ELOQUENT AREAS (2014) (0)
- Utility and limits of an imaging follow-up in evaluation of response and evolution of cerebral tumors after radiotherapy. (1990) (0)
- [Future prospects]. (2007) (0)
- 361PEffect of silibinin nutraceutical supplementation in brain metastases of patients with advanced lung cancer (2017) (0)
- Epilepsy in CNS Metastases (2019) (0)
- Ependymomas of childhood: pathological study of 100 cases for survival analysis (1989) (0)
- Bevacizumab and temozolomide in secondary gliomatosis from gemistocytic astrocytoma: a case report (2012) (0)
- OS1.4 Liquid biopsy of the CSF in a series of GBM patients: preliminary results (2019) (0)
- Monitoring of cognitive functions and quality of life, in glioblastomas treated with regorafenib (2021) (0)
- CTNI-25. REGORAFENIB IN RECURRENT GLIOBLASTOMA PATIENTS: A MULTICENTRIC REAL-LIFE STUDY (2022) (0)
- A CAD system for cerebral glioma in Magnetic Resonance Diffusion Tensor Images: semiautomatic segmentation and therapy follow up (2012) (0)
- Efficacy of topiramate in patients with gliomas (2007) (0)
- Beyond Semantics: The Need to Better Categorize Patients With Cancer (2013) (0)
- Does intensification of chemotherapy in anaplastic oligodendrogliomas still have a role? (2017) (0)
- Fourth Congress of the Italian Association of Neuro-Oncology (1995) (0)
- OS2.3 Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib in relapsed glioblastoma patients (2018) (0)
- Editorial: Hot Topics in Neuro-Oncology. (2018) (0)
- Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases (2023) (0)
- Advocacy for brain tumours (2019) (0)
- Is there a Role for Bevacizumab in Non-Glial Tumors? (2015) (0)
- Table of Content Editorial 4 (2014) (0)
- P05.47 Long-lasting response in spinal metastases from ALK rearranged Non-Small-Cell Lung Cancer treated with different ALK inhibitors (2018) (0)
- Sixteenth Meeting of the European Neurological Society 27–31 May 2006, Lausanne, Switzerland (2006) (0)
- Glomus Tumors, Paragangliomas (1997) (0)
- Highlights from the literature (1957) (0)
- MS-22NEOPLASTIC MENINGITIS FROM EPENDYMOMAS OF THE ADULT: A RETROSPECTIVE ANALYSIS. (2014) (0)
- 431PBEVACIZUMAB AND FOTEMUSTINE FOR RECURRENT HIGH GRADE GLIOMAS. (2014) (0)
- Seventeenth Meeting of the European Neurological Society 16–20 June 2007, Rhodes, Greece (2007) (0)
- Classification and Nosography of Neuroepithelial Tumors (1993) (0)
- Radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) in the treatment of brain metastases (2006) (0)
- NIMG-53. GLUTAMATE/GABA RATIO ON MRS IS ELEVATED IN PATIENTS WITH LOWER GRADE GLIOMAS AND SEIZURES (2020) (0)
- High speed autoradiography on brain tissue sections. (1981) (0)
- Brain Tumour-Related Epilepsy: Impact of Grading and Treatments in a Cohort of Molecularly Defined Lower-Grade Gliomas (2022) (0)
- P09.08 Clinical validation of integrated diagnosis in low-grade glioma (LGG). (2016) (0)
- GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology): Analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first relapse following Stupp regimen. (2015) (0)
- P01.054 Patterns of first tumor progression and impact on survival of salvage therapies in low-grade gliomas following initial chemotherapy with temozolomide (2018) (0)
- 8703 ORAL Bevacizumab and Fotemustine for Recurrent Glioblastoma – Final Results of a Multicenter Phase II Study of AINO (Italian Association of Neuro-Oncology) (2011) (0)
- Center for Neuro-Oncology in Turin (Italy) (2018) (0)
- O10.06A PHASE II STUDY OF AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY) ON BEVACIZUMAB AND FOTEMUSTINE FOR RECURRENT GLIOBLASTOMA: OUTCOME, PATTERNS OF RELAPSE AND SALVAGE TREATMENTS (2014) (0)
- PS1 - 177 Diagnosing and Treating Leptomeningeal Metastasis across Europe: A Web-Based Survey (2016) (0)
- Fifth congress of the Italian association of Neuro-Oncology october 2-3-4, 1997 Pavia, Salice Terme (2005) (0)
- PCSM-08EFFICACY AND TOLERABILITY OF LACOSAMIDE IN PATIENTS WITH GLIOMA AND SEIZURES: A PROSPECTIVE STUDY (2015) (0)
- Does the duration of adjuvant temozolomide impact survival in glioblastoma patients? A retrospective analysis from an Italian registry (GLIOSTRY). (2016) (0)
- [Chemotherapy of cerebral tumours: data on malignant gliomas (author's transl)]. (1978) (0)
- Highlights from the literature (2015) (0)
- Frequency, patterns of care, and outcome of neoplastic meningitis (NM) from solid tumors in regione Piemonte, Italy: A prospective survey from a cancer network. (2010) (0)
- [Radiotherapy of cerebral metastases]. (1984) (0)
- Genomics and targeted therapy for meningiomas (2015) (0)
- P05.30 Intracranial meningiomas: a systematic analysis of prognostic factors for recurrence in a large surgical series (2018) (0)
- Gliomatosis cerebri with oligodendrocytic components: description of 1 case (2003) (0)
- CMET-43. COMPARISON OF LOCAL CONTROL OF BRAIN METASTASES WITH STEREOTACTIC RADIOSURGERY VERSUS SURGICAL RESECTION: A SECONDARY ANALYSIS OF EORTC 22952–26001 (2017) (0)
- Highlights from the Literature A phase II trial of neratinib for patients with HER2-positive breast cancer and brain MR studies of glioblastoma models treated with dual PI3K/mTOR inhibitor and (2016) (0)
- MORPHOLOGICAL APPROACHES TO THE PROBLEM OF NEO‐VASCULARIZATION IN MALIGNANT GLIOMAS: 118 (1987) (0)
- METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy. (2021) (0)
- BMET-22. DOES WHOLE BRAIN RADIOTHERAPY FOR OLIGOMETASTATIC BRAIN METASTASES TRANSLATE INTO A SURVIVAL BENEFIT FOR PATIENTS WITH A LIMITED COMPETING RISK FROM EXTRA-CRANIAL DISEASE? A SECONDARY ANALYSIS OF EORTC 22952-26001 (2016) (0)
- ACTR-67. PATTERNS OF CARE AND IMPACT ON SURVIVAL OF FIRST SALVAGE THERAPY IN HIGH-RISK GRADE II GLIOMAS FOLLOWING INITIAL TEMOZOLOMIDE (2019) (0)
- R24Efficacy and safety of the VEGF inhibitor bevacizumab in combination with fotemustine for high-grade gliomas (2015) (0)
- Choroid Plexus Tumors (1993) (0)
- Abstract PO-068: S100A9 mediates radiation resistance of brain metastasis (2021) (0)
- CMET-40. LONG-LASTING RESPONSE IN SPINAL METASTASES FROM ALK REARRANGED NON-SMALL-CELL LUNG CANCER TREATED WITH DIFFERENT ALK INHIBITORS (2018) (0)
- Prognostic value of histological features in cerebral astrocytomas (1986) (0)
- Newly diagnosed Glioblastoma Multiforme (GBM) during COVID-19 pandemic: changes in therapeutic approach to minimize in-hospital SARS-COV-2 contagion in pre-vaccine era (2022) (0)
- Brain Metastases – Clinical Challenges and Recent Advances (2019) (0)
- ACTR-72. IDH-WILD TYPE GRADE II GLIOMAS: A RETROSPECTIVE SERIES OF ITALIAN ASSOCIATION OF NEURO-ONCOLOGY (2018) (0)
- Preoperative chemotherapy as a new strategy of treatment for low-grade gliomas in eloquent areas: A phase II study. (2014) (0)
- Online Database Featuring Author , Key Word and Full-Text Search Guidelines on the Management of Low-grade Gliomas : EANO Task Force Report (2018) (0)
- SURG-10. PROGNOSTIC IMPORTANCE OF THE EXTENT OF RESECTION IN IDH-WILD TYPE GRADE II ASTROCYTOMAS ACCORDING TO PTERT MUTATION (2020) (0)
- Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery (2020) (0)
- Sistemi di Computer-Assisted Detection e di Analisi di Dati Bio-medici (2013) (0)
- EPID-27GLIOSTRY (GLIOBLASTOMA REGISTRY) OF THE AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY): ANALYSIS OF FACTORS INFLUENCING SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING THE NITROSOUREA FOTEMUSTINE AT FIRST PROGRESSION FOLLOWING THE STUPP REGIMEN (2015) (0)
- THE ADDITION OF THIOTEPA AND RITUXIMAB TO HIGH DOSES OF ANTIMETABOLITES SIGNIFICANTLY IMPROVES OUTCOME IN PRIMARY CNS LYMPHOMA: THE FIRST RANDOMIZATION OF THE IELSG #32 TRIAL (2015) (0)
- [Efficacy of liposomal cytarabine in neoplastic meningitis]. (2007) (0)
- Assessement of clinical prognostic factors in elderly glioblastoma patients: An unmet need (2021) (0)
- BSCI-02. METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy (2021) (0)
- Featuring Author , Key Word and Full-Text Search Guidelines on the Management of Low-grade Gliomas : EANO Task Force Report (2016) (0)
- P16.34BEVACIZUMAB TREATMENT FOR ACOUSTIC NEURINOMA IN NEUROFIBROMATOSIS TYPE 2: A CASE REPORT (2014) (0)
- Highlights from the literature (1960) (0)
- Neoplastic meningitis: Clinico-diagnostic aspects[Meningite neoplastica: Aspetti clinico-diagnostici] (2006) (0)
- Whole-braın radıotherapy versus observatıon after radıosurgery or surgery of 1-3 braın metastases-results of the eortc 22952-26001 phase ııı study (2009) (0)
- P05.89 Comparison of local control of brain metastases with stereotactic radiosurgery versus surgical resection: A secondary analysis of EORTC 22952–26001 (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Riccardo Soffietti?
Riccardo Soffietti is affiliated with the following schools:
